CIII allows people who have tried at least two oral antidepressants to use the spray on its own – without the need for more ...

This isn’t considered true addiction, but rather a “physical ... Breaking free from nasal spray dependency can be challenging but is possible. Gradual reduction or “weaning off” the ...

The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment of major depression in ...

School nurses, teachers or other people trained and qualified would be authorized to administer the nasal spray to a student or staff member experiencing symptoms of an opioid overdose.

Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the ...

Here's what MDs want you to know about Spravato, the latest FDA-approved standalone nasal spray for depression.

Researchers delivered a dose of the “love hormone” oxytocin via a nasal spray to participants and found that it decreased ...

The humble nasal strip has become an unlikely must-have fashion accessory for Gen Z - but their surging popularity could be in response to the devastation of people who get hooked on decongestant ...

The U.S. Food and Drug Administration ( FDA) has approved the use of a nasal spray as a standalone treatment for major depressive disorder, offering a new option for those struggling with ...

A new "powerful tool" for combatting opioid deaths isn't settled science. For that reason, the state is taking a measured ...

CIII nasal spray for adults living with major depressive disorder who have had an inadequate response to at least two oral ...